nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCD—renal system—muscle cancer	0.0296	0.132	CbGeAlD
Ingenol Mebutate—PRKCD—tendon—muscle cancer	0.0231	0.103	CbGeAlD
Ingenol Mebutate—PRKCD—bone marrow—muscle cancer	0.0224	0.0997	CbGeAlD
Ingenol Mebutate—PRKCA—embryo—muscle cancer	0.0215	0.096	CbGeAlD
Ingenol Mebutate—PRKCD—vagina—muscle cancer	0.0214	0.0955	CbGeAlD
Ingenol Mebutate—PRKCD—head—muscle cancer	0.0198	0.0882	CbGeAlD
Ingenol Mebutate—PRKCD—testis—muscle cancer	0.0191	0.0852	CbGeAlD
Ingenol Mebutate—PRKCA—smooth muscle tissue—muscle cancer	0.0169	0.0755	CbGeAlD
Ingenol Mebutate—PRKCA—renal system—muscle cancer	0.0163	0.0727	CbGeAlD
Ingenol Mebutate—PRKCA—tendon—muscle cancer	0.0127	0.0567	CbGeAlD
Ingenol Mebutate—PRKCA—head—muscle cancer	0.0109	0.0486	CbGeAlD
Ingenol Mebutate—PRKCA—testis—muscle cancer	0.0105	0.047	CbGeAlD
Ingenol Mebutate—PRKCD—Signaling Pathways in Glioblastoma—FOXO4—muscle cancer	0.00716	0.00923	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Melatonin metabolism and effects—FOXO1—muscle cancer	0.00697	0.00899	CbGpPWpGaD
Ingenol Mebutate—PRKCD—AGE/RAGE pathway—FOXO1—muscle cancer	0.00629	0.00811	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—KIDINS220—muscle cancer	0.00581	0.00749	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways in Glioblastoma—FOXO1—muscle cancer	0.00529	0.00682	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—CALD1—muscle cancer	0.005	0.00645	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—FOXO4—muscle cancer	0.00489	0.00631	CbGpPWpGaD
Ingenol Mebutate—PRKCD—VEGFR2 mediated cell proliferation—VEGFA—muscle cancer	0.00487	0.00628	CbGpPWpGaD
Ingenol Mebutate—PRKCD—B Cell Receptor Signaling Pathway—FOXO1—muscle cancer	0.00462	0.00596	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Validated transcriptional targets of TAp63 isoforms—CDKN2A—muscle cancer	0.00457	0.00589	CbGpPWpGaD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—CNR1—muscle cancer	0.00448	0.00577	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—KIDINS220—muscle cancer	0.00447	0.00576	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signaling of activated FGFR—FOXO4—muscle cancer	0.00444	0.00572	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Validated transcriptional targets of TAp63 isoforms—MDM2—muscle cancer	0.00443	0.00571	CbGpPWpGaD
Ingenol Mebutate—PRKCD—p53 pathway—CDKN2A—muscle cancer	0.00426	0.00549	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB Signaling Pathway—FOXO1—muscle cancer	0.00424	0.00547	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—FOXO4—muscle cancer	0.00417	0.00538	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—FOXO4—muscle cancer	0.00415	0.00535	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—FOXO4—muscle cancer	0.00415	0.00535	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—FOXO4—muscle cancer	0.00413	0.00533	CbGpPWpGaD
Ingenol Mebutate—PRKCD—p53 pathway—MDM2—muscle cancer	0.00413	0.00532	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—FOXO4—muscle cancer	0.00411	0.0053	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—FOXO4—muscle cancer	0.00411	0.0053	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—MDM2—muscle cancer	0.00407	0.00525	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—FOXO4—muscle cancer	0.00387	0.00499	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—FOXO4—muscle cancer	0.00387	0.00499	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—FOXO4—muscle cancer	0.00383	0.00494	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—FOXO4—muscle cancer	0.0038	0.0049	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—FOXO4—muscle cancer	0.00378	0.00488	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—FOXO1—muscle cancer	0.00361	0.00466	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—FOXO4—muscle cancer	0.00343	0.00442	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signaling of activated FGFR—FOXO1—muscle cancer	0.00328	0.00423	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways in Glioblastoma—CDKN2A—muscle cancer	0.00327	0.00422	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	0.00321	0.00413	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFR1 specific signals—VEGFA—muscle cancer	0.00318	0.0041	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways in Glioblastoma—MDM2—muscle cancer	0.00317	0.00409	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Insulin Signaling—FOXO1—muscle cancer	0.0031	0.00399	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—FOXO1—muscle cancer	0.00308	0.00397	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—FOXO1—muscle cancer	0.00307	0.00395	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—FOXO1—muscle cancer	0.00307	0.00395	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—FOXO1—muscle cancer	0.00305	0.00393	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—FOXO1—muscle cancer	0.00304	0.00391	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—FOXO1—muscle cancer	0.00304	0.00391	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Kit receptor signaling pathway—KIT—muscle cancer	0.00301	0.00388	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Oncostatin M Signaling Pathway—VEGFA—muscle cancer	0.0029	0.00374	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.00286	0.00369	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—FOXO1—muscle cancer	0.00286	0.00368	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—FOXO1—muscle cancer	0.00286	0.00368	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—FOXO1—muscle cancer	0.00283	0.00365	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—FOXO1—muscle cancer	0.00281	0.00362	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—muscle cancer	0.0028	0.00361	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFR2 mediated cell proliferation—VEGFA—muscle cancer	0.0028	0.00361	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—FOXO1—muscle cancer	0.00279	0.0036	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—ANGPT2—muscle cancer	0.00276	0.00355	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—DMD—muscle cancer	0.00274	0.00353	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—FOXO4—muscle cancer	0.00267	0.00344	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—FOXO4—muscle cancer	0.00264	0.0034	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.0026	0.00335	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—FOXO4—muscle cancer	0.00255	0.00329	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB Signaling Pathway—MDM2—muscle cancer	0.00255	0.00328	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—FOXO1—muscle cancer	0.00253	0.00326	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signaling of activated FGFR—KIT—muscle cancer	0.0025	0.00322	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—FOXO4—muscle cancer	0.0024	0.00309	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—FOXO4—muscle cancer	0.00238	0.00307	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—FOXO4—muscle cancer	0.00238	0.00307	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—FOXO4—muscle cancer	0.00237	0.00306	CbGpPWpGaD
Ingenol Mebutate—PRKCD—p53 pathway—TP53—muscle cancer	0.00237	0.00305	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—FOXO4—muscle cancer	0.00236	0.00304	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—KIT—muscle cancer	0.00235	0.00303	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—KIT—muscle cancer	0.00234	0.00301	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—KIT—muscle cancer	0.00233	0.003	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—KIT—muscle cancer	0.00231	0.00298	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—FOXO4—muscle cancer	0.00222	0.00286	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—FOXO4—muscle cancer	0.00222	0.00286	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—FOXO4—muscle cancer	0.0022	0.00284	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Oncostatin M Signaling Pathway—TP53—muscle cancer	0.00219	0.00283	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—FOXO4—muscle cancer	0.00218	0.00281	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—KIT—muscle cancer	0.00218	0.00281	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—KIT—muscle cancer	0.00218	0.00281	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—FOXO4—muscle cancer	0.00217	0.0028	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—KIT—muscle cancer	0.00216	0.00278	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—KIT—muscle cancer	0.00214	0.00276	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—KIT—muscle cancer	0.00213	0.00274	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.00209	0.00269	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—FOXO1—muscle cancer	0.00197	0.00254	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—FOXO4—muscle cancer	0.00197	0.00254	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signaling of activated FGFR—MDM2—muscle cancer	0.00197	0.00254	CbGpPWpGaD
Ingenol Mebutate—PRKCD—VEGFA-VEGFR2 Pathway—VEGFA—muscle cancer	0.00195	0.00251	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—FOXO1—muscle cancer	0.00195	0.00251	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.00193	0.00249	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—FOXO1—muscle cancer	0.00188	0.00243	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—CDKN2A—muscle cancer	0.00188	0.00242	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—MDM2—muscle cancer	0.00185	0.00238	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—MDM2—muscle cancer	0.00184	0.00237	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by VEGF—VEGFA—muscle cancer	0.00184	0.00237	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—MDM2—muscle cancer	0.00183	0.00236	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—MDM2—muscle cancer	0.00182	0.00235	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—MDM2—muscle cancer	0.00182	0.00235	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways in Glioblastoma—TP53—muscle cancer	0.00182	0.00235	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—FOXO1—muscle cancer	0.00178	0.00229	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—FOXO1—muscle cancer	0.00177	0.00228	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—FOXO1—muscle cancer	0.00176	0.00227	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—FOXO1—muscle cancer	0.00176	0.00227	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—FOXO1—muscle cancer	0.00175	0.00226	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—FOXO1—muscle cancer	0.00174	0.00225	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—MDM2—muscle cancer	0.00171	0.00221	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—MDM2—muscle cancer	0.00171	0.00221	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—MDM2—muscle cancer	0.0017	0.00219	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—MDM2—muscle cancer	0.00168	0.00217	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—MDM2—muscle cancer	0.00168	0.00216	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—KIDINS220—muscle cancer	0.00167	0.00216	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—VEGFA—muscle cancer	0.00167	0.00215	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—FOXO1—muscle cancer	0.00164	0.00212	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—FOXO1—muscle cancer	0.00164	0.00212	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—FOXO1—muscle cancer	0.00163	0.0021	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—FOXO1—muscle cancer	0.00161	0.00208	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—muscle cancer	0.00161	0.00207	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—FOXO1—muscle cancer	0.0016	0.00207	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—ANGPT2—muscle cancer	0.00158	0.00204	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Wnt Signaling Pathway and Pluripotency—TP53—muscle cancer	0.00153	0.00197	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.00152	0.00196	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—FOXO4—muscle cancer	0.00151	0.00195	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—FOXO4—muscle cancer	0.0015	0.00194	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—KIT—muscle cancer	0.0015	0.00193	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.00149	0.00192	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—KIT—muscle cancer	0.00148	0.00191	CbGpPWpGaD
Ingenol Mebutate—PRKCA—M Phase—BUB1B—muscle cancer	0.00148	0.0019	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB Signaling Pathway—TP53—muscle cancer	0.00146	0.00188	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—FOXO1—muscle cancer	0.00145	0.00187	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—KIT—muscle cancer	0.00143	0.00185	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Mitotic M-M/G1 phases—BUB1B—muscle cancer	0.00135	0.00174	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—KIT—muscle cancer	0.00135	0.00174	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	0.00134	0.00173	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—KIT—muscle cancer	0.00134	0.00173	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—IGF2—muscle cancer	0.00134	0.00173	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—KIT—muscle cancer	0.00134	0.00172	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—KIT—muscle cancer	0.00133	0.00171	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—PTGS2—muscle cancer	0.00131	0.00169	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CD34—muscle cancer	0.00129	0.00166	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—TP53—muscle cancer	0.00126	0.00162	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—KIT—muscle cancer	0.00125	0.00161	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—KIT—muscle cancer	0.00125	0.00161	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—KIT—muscle cancer	0.00124	0.0016	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—KIT—muscle cancer	0.00123	0.00158	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—KIT—muscle cancer	0.00122	0.00158	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—muscle cancer	0.00119	0.00153	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—MDM2—muscle cancer	0.00118	0.00152	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—MED12—muscle cancer	0.00117	0.00151	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—MDM2—muscle cancer	0.00117	0.00151	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—MDM2—muscle cancer	0.00113	0.00146	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—VEGFA—muscle cancer	0.00112	0.00144	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—FOXO1—muscle cancer	0.00112	0.00144	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—PTCH1—muscle cancer	0.00111	0.00144	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—FOXO1—muscle cancer	0.00111	0.00143	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.00111	0.00143	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—TP53—muscle cancer	0.00109	0.00141	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.00109	0.00141	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—MDM2—muscle cancer	0.00106	0.00137	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—MDM2—muscle cancer	0.00106	0.00136	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—VEGFA—muscle cancer	0.00106	0.00136	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—MDM2—muscle cancer	0.00105	0.00136	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—MDM2—muscle cancer	0.00105	0.00135	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—TP53—muscle cancer	0.00105	0.00135	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—CNR1—muscle cancer	0.00104	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—TP53—muscle cancer	0.00103	0.00132	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—BUB1B—muscle cancer	0.00101	0.0013	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ENO2—muscle cancer	0.000991	0.00128	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—MDM2—muscle cancer	0.000985	0.00127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—MDM2—muscle cancer	0.000985	0.00127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—MDM2—muscle cancer	0.000976	0.00126	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—MDM2—muscle cancer	0.000967	0.00125	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—MDM2—muscle cancer	0.000963	0.00124	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KIDINS220—muscle cancer	0.00096	0.00124	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CNR1—muscle cancer	0.00094	0.00121	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000926	0.00119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—FH—muscle cancer	0.000926	0.00119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—BUB1B—muscle cancer	0.000905	0.00117	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—HMGA1—muscle cancer	0.000901	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000893	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000893	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—TP53—muscle cancer	0.000878	0.00113	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—FOXO4—muscle cancer	0.000875	0.00113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000872	0.00112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—FOXO4—muscle cancer	0.000863	0.00111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—KIT—muscle cancer	0.000852	0.0011	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—KIT—muscle cancer	0.000846	0.00109	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—FOXO4—muscle cancer	0.000808	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TP53—muscle cancer	0.000781	0.00101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—IGF2—muscle cancer	0.000769	0.000992	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD34—muscle cancer	0.00074	0.000953	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000704	0.000907	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—MDM2—muscle cancer	0.000684	0.000882	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MED12—muscle cancer	0.000673	0.000867	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—MDM2—muscle cancer	0.000671	0.000865	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—MDM2—muscle cancer	0.000666	0.000859	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PTCH1—muscle cancer	0.000658	0.000848	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—FOXO1—muscle cancer	0.000647	0.000833	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PTCH1—muscle cancer	0.00064	0.000825	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—FOXO1—muscle cancer	0.000638	0.000822	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000626	0.000807	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—FOXO1—muscle cancer	0.000597	0.000769	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CNR1—muscle cancer	0.000595	0.000767	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ENO2—muscle cancer	0.000569	0.000734	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FOXO4—muscle cancer	0.000566	0.00073	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—VEGFA—muscle cancer	0.000562	0.000724	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CNR1—muscle cancer	0.000556	0.000716	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CNR1—muscle cancer	0.00054	0.000696	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000532	0.000685	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—MED12—muscle cancer	0.000523	0.000674	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HMGA1—muscle cancer	0.000518	0.000667	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FOXO4—muscle cancer	0.000503	0.000648	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—KIT—muscle cancer	0.000493	0.000635	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—KIT—muscle cancer	0.000486	0.000626	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ENO2—muscle cancer	0.000477	0.000615	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FOXO4—muscle cancer	0.000464	0.000598	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDKN2A—muscle cancer	0.000462	0.000596	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—KIT—muscle cancer	0.000455	0.000586	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IGF2—muscle cancer	0.000454	0.000585	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TP53—muscle cancer	0.000425	0.000547	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FOXO1—muscle cancer	0.000418	0.000539	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDKN2A—muscle cancer	0.000413	0.000533	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—MDM2—muscle cancer	0.000401	0.000517	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—MDM2—muscle cancer	0.000388	0.0005	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—MDM2—muscle cancer	0.000383	0.000493	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTCH1—muscle cancer	0.000378	0.000487	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FOXO1—muscle cancer	0.000371	0.000479	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MDM2—muscle cancer	0.000358	0.000462	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PTGS2—muscle cancer	0.000345	0.000445	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FOXO1—muscle cancer	0.000343	0.000442	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FOXO4—muscle cancer	0.000325	0.000419	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—VEGFA—muscle cancer	0.000323	0.000416	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CNR1—muscle cancer	0.000319	0.000411	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—KIT—muscle cancer	0.000319	0.000411	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—KIT—muscle cancer	0.000283	0.000365	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—KIT—muscle cancer	0.000261	0.000337	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IGF2—muscle cancer	0.000261	0.000336	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MDM2—muscle cancer	0.000251	0.000323	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—muscle cancer	0.000244	0.000314	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FOXO1—muscle cancer	0.00024	0.000309	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—muscle cancer	0.00023	0.000297	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—MDM2—muscle cancer	0.000223	0.000287	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MDM2—muscle cancer	0.000206	0.000265	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PTGS2—muscle cancer	0.000198	0.000256	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—VEGFA—muscle cancer	0.00019	0.000246	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KIT—muscle cancer	0.000183	0.000236	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PTGS2—muscle cancer	0.000166	0.000214	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MDM2—muscle cancer	0.000144	0.000186	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—muscle cancer	0.000144	0.000186	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VEGFA—muscle cancer	0.000109	0.000141	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—muscle cancer	8.27e-05	0.000107	CbGpPWpGaD
